What is PROCEPT BioRobotics Financial Strength?
PROCEPT BioRobotics has the Financial Strength Rank of 7.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:
1. The debt burden that the company has as measured by its
Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3.
Altman Z-Score.
PROCEPT BioRobotics did not have earnings to cover the interest expense.
PROCEPT BioRobotics's debt to revenue ratio for the quarter that ended in Mar. 2024 was 0.46.
As of today, PROCEPT BioRobotics's Altman Z-Score is 16.54.
Competitive Comparison of PROCEPT BioRobotics's Financial Strength
For the Medical Devices subindustry, PROCEPT BioRobotics's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PROCEPT BioRobotics's Financial Strength Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PROCEPT BioRobotics's Financial Strength distribution charts can be found below:
* The bar in red indicates where PROCEPT BioRobotics's Financial Strength falls into.
PROCEPT BioRobotics Financial Strength Calculation
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
PROCEPT BioRobotics's Interest Expense for the
months ended in Mar. 2024 was $-1.0 Mil. Its Operating Income for the
months ended in Mar. 2024 was $-27.6 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $79.7 Mil.
PROCEPT BioRobotics's Interest Coverage for the quarter that ended in Mar. 2024 is
| PROCEPT BioRobotics did not have earnings to cover the interest expense. |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
PROCEPT BioRobotics's Debt to Revenue Ratio for the quarter that ended in Mar. 2024 is
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
PROCEPT BioRobotics has a Z-score of 16.54, indicating it is in Safe Zones. This implies the Z-Score is strong.
Good Sign:
Altman Z-score of 16.54 is strong.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PROCEPT BioRobotics (PROCEPT BioRobotics) Business Description
Traded in Other Exchanges
N/A
Address
900 Island Drive, Redwood, CA, USA, 94065
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.
Executives
| Alaleh Nouri |
officer: SVP, GEN COUNSEL, CORP. SEC. |
1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089 |
| Kevin Waters |
officer: Senior VP, CFO |
1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089 |
| Frederic H Moll |
director |
C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086 |
| Wood Morgan Colby |
director |
C/O PROCEPT BIOROBOTICS CORPORATION, 900 ISLAND DRIVE, REDWOOD CA 94065 |
| Reza Zadno |
director, officer: President, CEO |
2710 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025 |
| Hisham Shiblaq |
officer: SVP, Commercial Operations |
C/O PROCEPT BIOROBOTICS CORPORATION, 900 ISLAND DRIVE, REDWOOD CITY CA 94065 |
| Thomas M Krummel |
director |
C/O CALIFORNIA WATER SERVICE GROUP, 1720 N. FIRST STREET, SAN JOSE CA 95118 |
| Viking Global Investors Lp |
10 percent owner |
600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901 |
| Viking Global Opportunities Parent Gp Llc |
10 percent owner |
600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901 |
| Dragsa 88 Llc |
10 percent owner |
55 RAILROAD AVE, GREENWICH CT 06830 |
| Rose Sharon Shabet |
10 percent owner |
600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901 |
| Viking Global Opportunities Illiquid Investments Sub-master Lp |
10 percent owner |
600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901 |
| Viking Global Opportunities Gp Llc |
10 percent owner |
55 RAILROAD AVENUE, GREENWICH CT 06830 |
| Viking Global Opportunities Portfolio Gp Llc |
10 percent owner |
600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901 |
| David C. Ott |
10 percent owner |
600 WASHINGTON BLVD., FLOOR 11, STAMFORD CT 06901 |
PROCEPT BioRobotics (PROCEPT BioRobotics) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRCT has been successfully added to your